Visual Capitalist August 11, 2024
Freny Fernandes

Over the past few decades, the cost of insulin in the United States skyrocketed, affecting millions of people with diabetes relying on it every day.

Insulin is produced by three major manufacturers in the U.S.—Eli Lilly, Novo Nordisk, and Sanofi.

This infographic by Pernia Jamshed and Shabeeb Hammad focuses on the drastic price rise of Eli Lilly’s rapid-acting insulin, Humalog, using data sourced from Pharmaceutical Technology, NBC News, and Eli Lilly.

Cost of Insulin from 2004 to 2024

Humalog is one of the most well-known insulin brands globally. It is a fast-acting insulin that controls blood sugar levels in people with type 1 and type 2 diabetes.

In 1996, when it was first introduced, a 10 mL vial of Humalog...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article